MK-1496
MK-1496 is an orally active and highly selective PLK1 inhibitor. MK-1496 exerts antitumor effects by inducing G2/M phase arrest and apoptosis in tumor cells. MK-1496 can be used in research related to parotid gland carcinoma and small cell lung cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1037254-47-9
- Formule: C14H24N2O
- Masse moléculaire:236.35
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
[1]|
PLK1 |
Chemical Information
-
CAS No. 1037254-47-9
-
Masse moléculaire 236.35
-
Formule C14H24N2O
-
SMILES
CC(C)(C)NC[C@H](C1=CC=C(C=C1)[C@@H](N)C)O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)